RudaCure attended BioKorea 2021, held at COEX in Seoul, and used the opportunity to showcase its dry eye disease treatment candidate RCI001 and pain treatment pipeline RCI002 to major domestic and international pharmaceutical companies and investors.
Through various networking sessions at the conference, the company engaged in active discussions on future research collaboration and technology licensing opportunities.